Lumbosacral Muscle Strain
Conditions
Keywords
medical education, clinical decisionmaking, pharmaceutical marketing
Brief summary
The purpose of this study is to determine whether physicians can be educated to better handle inappropriate requests from patients for direct-to-consumer advertised prescription medications.
Detailed description
Since changes in FDA regulation direct-to-consumer advertising (DTCA), pharmaceutical companies have expended increasing resources to market their products to the public. This has led to increased awareness of diseases and potential treatments, but it has also created more public demand for medications that may not be appropriate for a patient's clinical presentation. This study aims to provide physicians with the knowledge and skills required to help them address inappropriate DTCA medication requests from patients.
Interventions
OTHERWeb-based educational modules
Interactive case-based modules that includes video vignettes of clinical interactions between hypothetical patients interacting with physicians
Sponsors
Attorney General Consumer & Prescriber Education Grant
American Medical Association
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Caregiver)
Eligibility
Sex/Gender
ALL
Healthy volunteers
Yes
Inclusion criteria
* Resident physicians in internal medicine or family medicine specialties at participating study sites
Exclusion criteria
* Completed less than 10 months of residency
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decision to prescribe celecoxib | — |
Countries
United States
Outcome results
None listed